Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis
Autoría
Montes Moreno, Santiago
; Batllé López, Ana; González de Villambrosía, Sonia; Sánchez-Espiridión, Beatriz; Cereceda, Laura; González-Barca, Eva; Noelia Purroy, Noelia; Pardal, Emilia; Martín, Alejandro; Grande, Carlos; Mazorra Macho, Francisco; Insunza, Andrés; Quero, Cristina; Aguiar, David; Cruz, Miguel Ángel; Rueda, Antonio; Llanos, Marta; Gómez Codina, José; Piris Pinilla, Miguel Ángel; [et al.]Fecha
2014Derechos
Atribución-NoComercial 3.0 España © Ferrata Storti Foundation. Santiago Montes Moreno...[ et al.], 2014, Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. "Obtained from the Haematologica Journal website http://www.haematologica.org"
Publicado en
haematologica 2014; 99: e138-e141
Editorial
Ferrata Storti Foundation
Colecciones a las que pertenece
- D02 Artículos [403]
- D06 Artículos [576]
- IDIVAL Artículos [864]
![Atribución-NoComercial 3.0 España © Ferrata Storti Foundation. Santiago Montes Moreno...[ et al.], 2014, Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. "Obtained from the Haematologica Journal website http://www.haematologica.org"](/xmlui/themes/Mirage2//images/cc-ship.gif)
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial 3.0 España © Ferrata Storti Foundation. Santiago Montes Moreno...[ et al.], 2014, Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. "Obtained from the Haematologica Journal website http://www.haematologica.org"
